Cargando…
Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils
Interferons (IFNs) are induced by viruses and are the main regulators of the host antiviral response. They balance tissue tolerance and immune resistance against viral challenges. Like all cells in the human body, neutrophils possess the receptors for IFNs and contribute to antiviral host defense. T...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125486/ https://www.ncbi.nlm.nih.gov/pubmed/33946935 http://dx.doi.org/10.3390/ijms22094726 |
_version_ | 1783693517256654848 |
---|---|
author | Stegelmeier, Ashley A. Darzianiazizi, Maedeh Hanada, Kiersten Sharif, Shayan Wootton, Sarah K. Bridle, Byram W. Karimi, Khalil |
author_facet | Stegelmeier, Ashley A. Darzianiazizi, Maedeh Hanada, Kiersten Sharif, Shayan Wootton, Sarah K. Bridle, Byram W. Karimi, Khalil |
author_sort | Stegelmeier, Ashley A. |
collection | PubMed |
description | Interferons (IFNs) are induced by viruses and are the main regulators of the host antiviral response. They balance tissue tolerance and immune resistance against viral challenges. Like all cells in the human body, neutrophils possess the receptors for IFNs and contribute to antiviral host defense. To combat viruses, neutrophils utilize various mechanisms, such as viral sensing, neutrophil extracellular trap formation, and antigen presentation. These mechanisms have also been linked to tissue damage during viral infection and inflammation. In this review, we presented evidence that a complex cross-regulatory talk between IFNs and neutrophils initiates appropriate antiviral immune responses and regulates them to minimize tissue damage. We also explored recent exciting research elucidating the interactions between IFNs, neutrophils, and severe acute respiratory syndrome-coronavirus-2, as an example of neutrophil and IFN cross-regulatory talk. Dissecting the IFN-neutrophil paradigm is needed for well-balanced antiviral therapeutics and development of novel treatments against many major epidemic or pandemic viral infections, including the ongoing pandemic of the coronavirus disease that emerged in 2019. |
format | Online Article Text |
id | pubmed-8125486 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81254862021-05-17 Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils Stegelmeier, Ashley A. Darzianiazizi, Maedeh Hanada, Kiersten Sharif, Shayan Wootton, Sarah K. Bridle, Byram W. Karimi, Khalil Int J Mol Sci Review Interferons (IFNs) are induced by viruses and are the main regulators of the host antiviral response. They balance tissue tolerance and immune resistance against viral challenges. Like all cells in the human body, neutrophils possess the receptors for IFNs and contribute to antiviral host defense. To combat viruses, neutrophils utilize various mechanisms, such as viral sensing, neutrophil extracellular trap formation, and antigen presentation. These mechanisms have also been linked to tissue damage during viral infection and inflammation. In this review, we presented evidence that a complex cross-regulatory talk between IFNs and neutrophils initiates appropriate antiviral immune responses and regulates them to minimize tissue damage. We also explored recent exciting research elucidating the interactions between IFNs, neutrophils, and severe acute respiratory syndrome-coronavirus-2, as an example of neutrophil and IFN cross-regulatory talk. Dissecting the IFN-neutrophil paradigm is needed for well-balanced antiviral therapeutics and development of novel treatments against many major epidemic or pandemic viral infections, including the ongoing pandemic of the coronavirus disease that emerged in 2019. MDPI 2021-04-29 /pmc/articles/PMC8125486/ /pubmed/33946935 http://dx.doi.org/10.3390/ijms22094726 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Stegelmeier, Ashley A. Darzianiazizi, Maedeh Hanada, Kiersten Sharif, Shayan Wootton, Sarah K. Bridle, Byram W. Karimi, Khalil Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils |
title | Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils |
title_full | Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils |
title_fullStr | Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils |
title_full_unstemmed | Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils |
title_short | Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils |
title_sort | type i interferon-mediated regulation of antiviral capabilities of neutrophils |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125486/ https://www.ncbi.nlm.nih.gov/pubmed/33946935 http://dx.doi.org/10.3390/ijms22094726 |
work_keys_str_mv | AT stegelmeierashleya typeiinterferonmediatedregulationofantiviralcapabilitiesofneutrophils AT darzianiazizimaedeh typeiinterferonmediatedregulationofantiviralcapabilitiesofneutrophils AT hanadakiersten typeiinterferonmediatedregulationofantiviralcapabilitiesofneutrophils AT sharifshayan typeiinterferonmediatedregulationofantiviralcapabilitiesofneutrophils AT woottonsarahk typeiinterferonmediatedregulationofantiviralcapabilitiesofneutrophils AT bridlebyramw typeiinterferonmediatedregulationofantiviralcapabilitiesofneutrophils AT karimikhalil typeiinterferonmediatedregulationofantiviralcapabilitiesofneutrophils |